Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ONDANSETRON for Neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 34 adverse event reports in the FDA FAERS database where ONDANSETRON was used for Neoplasm malignant.

Most Reported Side Effects for ONDANSETRON

Side Effect Reports % Deaths Hosp.
Nausea 2,986 13.2% 369 1,126
Vomiting 1,990 8.8% 405 928
Off label use 1,905 8.4% 449 658
Drug ineffective 1,856 8.2% 234 505
Pain 1,666 7.3% 219 457
Constipation 1,596 7.0% 392 458
Foetal exposure during pregnancy 1,571 6.9% 142 261
Pyrexia 1,555 6.9% 216 831
Maternal exposure during pregnancy 1,503 6.6% 22 226
Fatigue 1,440 6.3% 171 548
Headache 1,335 5.9% 163 441
Product use in unapproved indication 1,303 5.7% 179 338
Dyspnoea 1,203 5.3% 168 602
Diarrhoea 1,196 5.3% 109 495
Injury 1,179 5.2% 42 88

Other Indications for ONDANSETRON

Product used for unknown indication (7,342) Nausea (3,889) Vomiting (2,184) Prophylaxis of nausea and vomiting (2,049) Premedication (1,101) Foetal exposure during pregnancy (1,061) Vomiting in pregnancy (590) Antiemetic supportive care (500) Prophylaxis (413) Migraine (398)

Other Drugs Used for Neoplasm malignant

PALBOCICLIB (1,996) CAPECITABINE (1,493) PEMBROLIZUMAB (1,135) PACLITAXEL (984) CARBOPLATIN (977) NIVOLUMAB (947) OXALIPLATIN (823) PAZOPANIB (716) CYCLOPHOSPHAMIDE (685) FLUOROURACIL (676)

Related Pages

ONDANSETRON Full Profile All Neoplasm malignant Drugs ONDANSETRON Demographics ONDANSETRON Timeline